These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4577178)

  • 41. [Formation of interferon in the brain of baby mice after injection with some rhabdoviruses].
    Hofmann H; Kunz C
    Zentralbl Bakteriol Orig; 1969; 211(1):5-9. PubMed ID: 4393905
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term persistence of cell-mediated and humoral immune response in specifically resistant mice given live attenuated langat (E5 "14") virus.
    Gajdosová E; Mayer V
    Acta Virol; 1978 Mar; 22(2):131-8. PubMed ID: 26198
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A chick embryo attenuated strain (TP21 E5) of Langat virus. 3. The ability to protect against homologous virus and Powassan virus in cross-challenge experiments.
    Thind IS; Price WH
    Am J Epidemiol; 1966 Sep; 84(2):225-33. PubMed ID: 5920389
    [No Abstract]   [Full Text] [Related]  

  • 44. Seroepidemiologic studies in Oaxaca, Mexico. II. Survey for arbovirus antibody.
    Goldsmith RS; Zarate ML; Cedeño-Ferreira J; Antonio Paz E
    Arch Invest Med (Mex); 1979; 10(4):239-59. PubMed ID: 539866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.
    Kayser M; Klein H; Paasch I; Pilaski J; Blenk H; Heeg K
    J Med Virol; 1985 Sep; 17(1):35-45. PubMed ID: 2995571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virologic aspects in studies of Japanese and tick-borne encephalitis.
    Levkovich EN
    Jpn J Med Sci Biol; 1967 Dec; 20 Suppl():138-41. PubMed ID: 4298407
    [No Abstract]   [Full Text] [Related]  

  • 48. Pseudotyped viruses permit rapid detection of neutralizing antibodies in human and equine serum against Venezuelan equine encephalitis virus.
    Kolokoltsov AA; Wang E; Colpitts TM; Weaver SC; Davey RA
    Am J Trop Med Hyg; 2006 Oct; 75(4):702-9. PubMed ID: 17038698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure.
    Braid LR; Hu WG; Davies JE; Nagata LP
    Stem Cells Transl Med; 2016 Aug; 5(8):1026-35. PubMed ID: 27334491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neutralization of arboviruses. I. Neutralization homologous virus-serum mixtures with two group B arboviruses.
    Westaway EG
    Virology; 1965 Aug; 26(4):517-27. PubMed ID: 5833310
    [No Abstract]   [Full Text] [Related]  

  • 52. Protection against tick-borne encephalitis virus isolated in Japan by active and passive immunization.
    Chiba N; Osada M; Komoro K; Mizutani T; Kariwa H; Takashima I
    Vaccine; 1999 Mar; 17(11-12):1532-9. PubMed ID: 10195790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of an all-or-none type of complement requirement in early neutralizing antibody against western equine encephalitis virus.
    Yoshino K; Morishima T; Aoki Y
    Jpn J Microbiol; 1971 Jan; 15(1):63-72. PubMed ID: 5313614
    [No Abstract]   [Full Text] [Related]  

  • 54. Studies on the immunizing potency of tick-borne encephalitis vaccines.
    Gall W
    Acta Microbiol Pol A; 1973; 5(3):279-85. PubMed ID: 4769562
    [No Abstract]   [Full Text] [Related]  

  • 55. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.
    Schmaljohn C; Vanderzanden L; Bray M; Custer D; Meyer B; Li D; Rossi C; Fuller D; Fuller J; Haynes J; Huggins J
    J Virol; 1997 Dec; 71(12):9563-9. PubMed ID: 9371620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
    Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
    J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Five year follow-up after primary vaccination against tick-borne encephalitis in children.
    Wittermann C; Izu A; Petri E; Gniel D; Fragapane E
    Vaccine; 2015 Apr; 33(15):1824-9. PubMed ID: 25728316
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An immunological profile of Balb/c mice protected from airborne challenge following vaccination with a live attenuated Venezuelan equine encephalitis virus vaccine.
    Bennett AM; Elvin SJ; Wright AJ; Jones SM; Phillpotts RJ
    Vaccine; 2000 Sep; 19(2-3):337-47. PubMed ID: 10930689
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Venezuelan equine encephalitis-specific immunoglobulin responses: live attenuated TC-83 versus inactivated C-84 vaccine.
    Engler RJ; Mangiafico JA; Jahrling P; Ksiazek TG; Pedrotti-Krueger M; Peters CJ
    J Med Virol; 1992 Dec; 38(4):305-10. PubMed ID: 1474379
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Determination of arbovirus group affiliation in the indirect hemagglutination reaction].
    Nikolaev VP; Gol'din RB; Gaĭdamovich SIa; Zmachinskaia VV; Obukhova VR
    Vopr Virusol; 1975; (5):607-10. PubMed ID: 54999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.